Google and Kaggle’s free AI agents course returns June 15-19, with vibe coding lessons, live sessions, and a hands-on ...
Major healthcare companies reported robust Q1 2026 results alongside aggressive strategic investments and acquisitions. Incyte, Johnson & Johnson, and Eli Lilly highlighted product launches, pipeline ...
Eli Lilly is stepping further into oncology with an agreement to acquire closely held Ajax Therapeutics for up to $2.3 billion in cash, a ...
USA Rare Earth will buy a Brazilian mine to secure supply of heavy rare earths outside of Asia.
Britain resumes acceptance of Ajax armoured vehicles from General Dynamics after safety improvements, keeping within existing ...
Ajax deal expands Lilly’s oncology pipeline; Hematology focus adds depth beyond GLP therapies; Healthcare strategy gains ...
Eli Lilly (NYSE:LLY) agreed to acquire Ajax Therapeutics for up to $2.3b, adding a Type II JAK2 inhibitor program for ...
Shares of Veradermics Inc. spiked as the first top-line readout from its registrational program for VDPHL-01 showed the oral, extended-release version of minoxidil surpassed expectations in men with ...
DASH, Ontario’s first dedicated academic integration program for immigrant and newcomer children, has formalised working ...
Southampton midfielder Caspar Jander was excellent in the FA Cup semi-final defeat on Saturday, and could have attracted more suitors.
Lilly will pay up to $2.3B for Ajax and its AJ1‑11095 myelofibrosis drug; proof‑of‑concept data expected in 2026.
Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results